"Albumin: analyte monograph"(PDF). Association for Clinical Biochemistry and Laboratory Medicine. Arquivado dende o orixinal(PDF) o 13 de novembro de 2012. Consultado o 23 June 2013.
Sugio S, Kashima A, Mochizuki S, Noda M, Kobayashi K (1999). "Crystal structure of human serum albumin at 2.5 A resolution". Protein Eng.12 (6): 439–46. PMID10388840. doi:10.1093/protein/12.6.439.
He XM, Carter DC (1992). "Atomic structure and chemistry of human serum albumin.". Nature358 (6383): 209–15. PMID1630489. doi:10.1038/358209a0.
Jakus V, Hrnciarová M, Cársky J, Krahulec B, Rietbrock N (1999). "Inhibition of nonenzymatic protein glycation and lipid peroxidation by drugs with antioxidant activity". Life Sci.65 (18–19): 1991–3. PMID10576452. doi:10.1016/S0024-3205(99)00462-2.
Mendez DL, Jensen RA, McElroy LA, Pena JM, Esquerra RM (December 2005). "The effect of non-enzymatic glycation on the unfolding of human serum albumin". Arch. Biochem. Biophys.444 (2): 92–9. PMID16309624. doi:10.1016/j.abb.2005.10.019.
Mohamadi-Nejada A, Moosavi-Movahedi AA,Safariana S, Naderi-Maneshc MH, Ranjbarc B, Farzamid B, Mostafavie H, Larijanif MB, Hakimelahi GH, A (July 2002). "The thermal analysis of nonezymatic glycosylation of human serum albumin: differential scanning calorimetry and circular dichroism studies". Thermochimica Acta389 (1–2): 141–151. doi:10.1016/S0040-6031(02)00006-0.
Marashi SA, Safarian S, Moosavi-Movahedi AA (2005). "Why major nonenzymatic glycation sites of human serum albumin are preferred to other residues?". Med. Hypotheses64 (4): 881. PMID15694713. doi:10.1016/j.mehy.2004.11.007.
Hawkins JW, Dugaiczyk A (1982). "The human serum albumin gene: structure of a unique locus". Gene 19 (1): 55–8. doi:10.1016/0378-1119(82)90188-3. PMID 6292049.
Sugio S, Kashima A, Mochizuki S, Noda M, Kobayashi K (1999). "Crystal structure of human serum albumin at 2.5 A resolution". Protein Eng.12 (6): 439–46. PMID10388840. doi:10.1093/protein/12.6.439.
He XM, Carter DC (1992). "Atomic structure and chemistry of human serum albumin.". Nature358 (6383): 209–15. PMID1630489. doi:10.1038/358209a0.
Day JF, Thorpe SR, Baynes JW (February 1979). "Nonenzymatically glucosylated albumin. In vitro preparation and isolation from normal human serum". J. Biol. Chem.254 (3): 595–7. PMID762083.
Iberg N, Flückiger R (October 1986). "Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites". J. Biol. Chem.261 (29): 13542–5. PMID3759977.
Jakus V, Hrnciarová M, Cársky J, Krahulec B, Rietbrock N (1999). "Inhibition of nonenzymatic protein glycation and lipid peroxidation by drugs with antioxidant activity". Life Sci.65 (18–19): 1991–3. PMID10576452. doi:10.1016/S0024-3205(99)00462-2.
Shaklai N, Garlick RL, Bunn HF (March 1984). "Nonenzymatic glycosylation of human serum albumin alters its conformation and function". J. Biol. Chem.259 (6): 3812–7. PMID6706980.
Mendez DL, Jensen RA, McElroy LA, Pena JM, Esquerra RM (December 2005). "The effect of non-enzymatic glycation on the unfolding of human serum albumin". Arch. Biochem. Biophys.444 (2): 92–9. PMID16309624. doi:10.1016/j.abb.2005.10.019.
Kańska U, Boratyński J (2002). "Thermal glycation of proteins by D-glucose and D-fructose". Arch. Immunol. Ther. Exp. (Warsz.)50 (1): 61–6. PMID11916310.
Rojas A, Romay S, González D, Herrera B, Delgado R, Otero K (February 2000). "Regulation of endothelial nitric oxide synthase expression by albumin-derived advanced glycosylation end products". Circ. Res.86 (3): E50–4. PMID10679490.
Garlick RL, Mazer JS (May 1983). "The principal site of nonenzymatic glycosylation of human serum albumin in vivo". J. Biol. Chem.258 (10): 6142–6. PMID6853480.
Marashi SA, Safarian S, Moosavi-Movahedi AA (2005). "Why major nonenzymatic glycation sites of human serum albumin are preferred to other residues?". Med. Hypotheses64 (4): 881. PMID15694713. doi:10.1016/j.mehy.2004.11.007.
"Albumin: analyte monograph"(PDF). Association for Clinical Biochemistry and Laboratory Medicine. Arquivado dende o orixinal(PDF) o 13 de novembro de 2012. Consultado o 23 June 2013.
